Beilloso Hyaluronic Acid

Manufacturer
Jiangxi Hemei Pharmaceutical Co., Ltd
Effective date
2025-09-25
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-01 20:34:23

Label at a glance#

ProductBeilloso Hyaluronic Acid
Active ingredientCLOTRIMAZOLE
Label structure12 sections

Dosage and administration

1.Use one applicator every 2-3 nights ,Wash hands thoroughy before beginning, 2.0pen the foil packet to remove the pre-filed applicator. 3.Twist of the protective cap. 4.Lying down with knees bent,gently insert until comfortable. 5.Slowly push the plunger to dispense the gel 6.Remove and properly discard the applicator。 7.Rest lying down for a few minutes to let the gel spread.

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Clotrimazole 1percent(30mg)

Purpose

OTC - PURPOSE SECTION

Relieves Vaginal ltching

Use

INDICATIONS & USAGE SECTION

Provides temporary relief from vaginal dryness and discomfort.Moisturizes and soothes the vaginal mucosa.

Warnings

WARNINGS SECTION

For vaginal use only,not for oral use. The product should not be used as a substitute for medicines and medical devices.

Do not use

OTC - DO NOT USE SECTION

Do not use if you are pregnant, during menstruation, or breastfeeding.Store in a dry and cool place at 20°C-25°C(68°F-77°F)

When Using

OTC - WHEN USING SECTION

·you experience abdominal pain, fever, chills, nausea, vomiting,or foul-smelling discharg. symptoms worsen or do not improve within 7 days.If this is the first time you are experiencing vaginal dryness or discomfort, consult your healthcare provider

Stop Use

OTC - STOP USE SECTION

·you experience abdominal pain, fever, chills, nausea, vomiting,or foul-smelling discharg. symptoms worsen or do not improve within 7 days.If this is the first time you are experiencing vaginal dryness or discomfort, consult your healthcare provider

Ask Doctor

OTC - ASK DOCTOR SECTION

·you experience abdominal pain, fever, chills, nausea, vomiting,or foul-smelling discharg. symptoms worsen or do not improve within 7 days.If this is the first time you are experiencing vaginal dryness or discomfort, consult your healthcare provider

Keep Oot Of Reach Of Children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children, for adults only.

Directions

DOSAGE & ADMINISTRATION SECTION

1.Use one applicator every 2-3 nights ,Wash hands thoroughy before beginning, 2.0pen the foil packet to remove the pre-filed applicator. 3.Twist of the protective cap. 4.Lying down with knees bent,gently insert until comfortable. 5.Slowly push the plunger to dispense the gel 6.Remove and properly discard the applicator。 7.Rest lying down for a few minutes to let the gel spread.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Purified Water,Dextran,Glucose, Propylene glycol, lnulin,Sodium hyaluronate,Hyaluronic acid, Sodium acetylated hyaluronate,Sodium hyaluronate crosspolymer, Dexpanthenol (Pro-vitamin B5),Rose flower water,Centella asiatica extract, Portulaca oleracea extract,Carbomer,L(+)-Arginine

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

11

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 17 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
84010-18884010-188-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 15 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
4a47d05f-6180-8d98-e063-6394a90ae3db3fabee60-8e62-5b68-e063-6394a90a16b22026-02-07WarningsExact identifier
spl set id: 3fabee60-8e62-5b68-e063-6394a90a16b2

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.